Bank & Trust CO Vincerx Pharma, Inc. Transaction History
Bank & Trust CO
- $123 Billion
- Q3 2024
A detailed history of Bank & Trust CO transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Bank & Trust CO holds 1,000 shares of VINC stock, worth $340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$340
Previous $810,000
11.6%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VINC
# of Institutions
29Shares Held
10.7MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX2.49MShares$846,0620.63% of portfolio
-
Armistice Capital, LLC New York, NY1.99MShares$675,9200.02% of portfolio
-
Sage Rhino Capital LLC1.7MShares$579,1600.28% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$303,1840.02% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct674KShares$229,2250.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $7.2M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...